Search
Press release
Animal Nutrition
March 10, 2016

Evonik announces price increase for ThreAMINO®

The Evonik Nutrition & Care GmbH is raising its price for ThreAMINO® (L-threonine 98.5% feed grade) by up to 15% per kilogram with immediate effect.

Existing contracts and supply agreements will be honored.

Evonik Nutrition & Care GmbH, specifically its Animal Nutrition Business Line translates over 60 years of experience in manufacturing essential amino acids for animal nutrition into solutions that meet the evolving needs of its customers in over one hundred countries. As Evonik now expands its scope to innovative nutritional feed additive solutions beyond amino acids, customers can count on Evonik to take nutrient effectiveness ever further and keep delivering value along with consistent quality. Around the planet, Evonik products and services are and will continue to be key to producing healthy, affordable food with fewer natural resources and a smaller environmental footprint.

Company information

Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.

About Nutrition & Care

The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around
€4.9 billion in 2015.

Disclaimer

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.